Pathogenic and chemical prevention of hepatocellular carcinoma

World Chinese Journal of Digestology

Volumn 13, Issue 16, 2005, Pages 2021-2025

  Guo, J ^a   Li, Q ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; AFLATOXIN; ALCOHOL; CD3 ANTIGEN; CD4 ANTIGEN; CHLOROPHYLL; COUMARIN; CURCUMIN; CYCLOOXYGENASE 2 INHIBITOR; DNA; DRINKING WATER; GINSENG EXTRACT; I KAPPA B; INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE; OLTIPRAZ; PHOSPHATIDYLINOSITOL 3 KINASE; POLYPHENOL; RETINOID; RETINOID X RECEPTOR ALPHA; SELENIUM;

CANCER PREVENTION; CANCER RISK; ENZYME ACTIVITY; HEREDITY; LIVER CELL CARCINOMA; REVIEW; TEA; WATER POLLUTION;

EID: 25444503258     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-543
2. Llovet JM, Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol 2003;38(Suppl 1): S136-149
3. Summerfield JA. Virus hepatitis update. J R Coll Physicians Lond 2000;34:381-385
4. Evans AA, Chen G, Ross EA, Shen FM, Lin WY, London WT. Eight-year follow-up of the 90 000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 2002;11: 369-376
5. Kiyosawa K, Tanaka E. Characteristics of hepatocellular carcinoma in Japan. Oncology 2002;62(Suppl 1):5-7
6. Fattovich G, Stroffolini T, Zagni I, Donate F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004;127(5 Suppl 1):S35-50
7. Omer RE, Verhoef L, Van't Veer P, Idris MO, Kadaru AM, Kampman E, Bunschoten A, Kok FJ. Peanut butter intake, GSTM1 genotype and hepatocellular carcinoma: a case-control study in Sudan. Cancer Causes Control 2001;12:23-32
8. Wang JS, Huang T, Su J, Liang F, Wei Z, Liang Y, Luo H, Kuang SY, Qian GS, Sun G, He X, Kensler TW, Groopman JD. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China. Cancer Epidemiol Biomarkers Prev 2001;10:143-146
9. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004;127(5 Suppl 1):S87-96
10. Hitzfeld BC, Hoger SJ, Dietrich DR. Cyanobacterial toxins: removal during drinking water treatment, and human risk assessment. Environ Health Perspect 2000;108(Suppl 1):113-122
11. Yu MW, Chang HC, Liaw YF, Lin SM, Lee SD, Liu CJ, Chen PJ, Hsiao TJ, Lee PH, Chen CJ. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 2000;92:1159-1164
12. Kakizoe T. Chemoprevention of cancer-focusing on clinical trials. Jpn J Clin Oncol 2003;33:421-442
13. Okuno M, Kojima S, Matsushima-Nishiwaki R, Tsurumi H, Muto Y, Friedman SL, Moriwaki H. Retinoids in cancer Chemoprevention. Curr Cancer Drug Targets 2004;4:285-298
14. Kojima S, Okuno M, Matsushima-Nishiwaki R, Friedman SL, Moriwaki H. Acyclic retinoid in the chemoprevention of hepatocellular carcinoma (review). Int J Oncol 2004;24:797-805
15. Sano T, Kagawa M, Okuno M, Ishibashi N, Hashimoto M, Yamamoto M, Suzuki R, Kohno H, Matsushima-Nishiwaki R, Takano Y, Tsurumi H, Kojima S, Friedman SL, Moriwaki H, Tanaka T. Prevention of rat hepatocarcinogenesis by acyclic retinoid is accompanied by reduction in emergence of both TGF-alpha-expressing oval-like cells and activated hepatic stellate cells. Nutr Cancer 2005;51:197-206
16. Okada S. Cancer chemoprevention as adjuvant therapy for hepatocellular carcinoma. Jpn J Clin Oncol 2001;31:357-358
17. Hino K, Okita K. Interferon therapy as chemoprevention of hepatocarcinogenesis in patients with chronic hepatitis C. J Antimicrob Chemother 2004;53:19-22
18. Camma C, Giunta M, Andreone P, Craxi A. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach. J Hepatol 2001;34:593-602
19. Piton A, Le Ferrec E, Langouet S, Rauch C, Petit E, Le Goff F, Guillouzo A, Morel F. Oltipraz regulates different categories of genes relevant to chemoprevention in human hepatocytes. Carcinogenesis 2005;26:343-351
20. Li Y, Su J, Qin L, Egner PA, Wang J, Groopman JD, Kensler TW, Roebuck BD. Reduction of aflatoxin B(1) adduct biomarkers by oltipraz in the tree shrew (Tupaia belangeri chinensis). Cancer Lett 2000;154:79-83
21. Wang JS, Shen X, He X, Zhu YR, Zhang BC, Wang JB, Qian GS, Kuang SY, Zarba A, Egner PA, Jacobson LP, Munoz A, Helzlsouer KJ, Groopman JD, Kensler TW. Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. J Natl Cancer Inst 1999;91:347-354
22. Sung YK, Hwang SY, Kim JO, Bae HI, Kim JC, Kim MK. The correlation between cyclooxygenase-2 expression and hepatocellular carcinogenesis. Mol Cells 2004;17:35-38
23. Hu KQ, Yu CH, Mineyama Y, McCracken JD, Hillebrand DJ, Hasan M. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor. Int J Oncol 2003;22:757-763
24. Yu MW, Horng IS, Hsu KH, Chiang YC, Liaw YF, Chen CJ. Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. Am J Epidemiol 1999;150:367-374
25. Thirunavukkarasu C, Prince Vijeya Singh J, Thangavel M, Selvendiran K, Sakthisekaran D. Dietary influence of selenium on the incidence of N-nitrosodiethylamine-induced hepatoma with reference to drug and glutathione metabolizing enzymes. Cell Biochem Funct 2002;20:347-356
26. Li W, Zhu Y, Yan X, Zhang Q, Li X, Ni Z, Shen Z, Yao H, Zhu J. The prevention of primary liver cancer by selenium in high risk populations. Zhonghua Yufang Yixue Zazhi 2000;34:336-338
27. Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, Dicato M, Diederich M. Chemopreventive and therapeutic effects of curcumin. Cancer Lett 2005;223:181-190
28. Lin JK. Suppression of protein kinase C and nuclear oncogene expression as possible action mechanisms of cancer chemoprevention by Curcumin. Arch Pharm Res 2004;27: 683-692
29. Chuang SE, Kuo ML, Hsu CH, Chen CR, Lin JK, Lai GM, Hsieh CY, Cheng AL. Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis 2000;21:331-335
30. Xu M, Orner GA, Bailey GS, Stoner GD, Horio DT, Dashwood RH. Post-initiation effects of chlorophyllin and indole-3-carbinol in rats given 1, 2-dimethylhydrazine or 2-amino-3-methyl-imidazo. Carcinogenesis 2001;22:309-314
31. Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, Zhang QN, Qian GS, Kuang SY, Gange SJ, Jacobson LP, Helzlsouer KJ, Bailey GS, Groopman JD, Kensler TW. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci USA 2001;98: 14601-14606
32. Wu XG, Zhu DH, Li X. Anticarcinogenic effect of red ginseng on the development of liver cancer induced by diethylnitrosamine in rats. J Korean Med Sci 2001;16(Suppl):S61-65
33. Jia X, Han C, Chen J. Effects of tea polyphenols and tea pigments on cell cycle of HepG2 cells. Weisheng Yanjiu 2002;31: 358-360
34. Okamoto T, Kobayashi T, Yoshida S. Chemical aspects of coumarin compounds for the prevention of hepatocellular carcinomas. Curr Med Chem Anti-Canc Agents 2005;5:47-51